PLK1 and neoplasm: Mahajan et al. developed superparamagnetic iron oxide nanoparticles coupled with siRNA directed against polo-like kinase-1 (PLK1), serving a dual purpose by both delivering siRNA to the tumor and facilitating non-invasive assessment of targeting efficiency via molecular imaging [56].